Form 4 for HRMY Harmony Biosciences Holdings, Inc.
Accepted 2025-09-02 00:00:00 ET · period of report 2025-08-28 · accession 0001213900-25-083535 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-09-02 | 2025-08-28 | HRMY | Sabater Juan A. | Dir, 10% | J - Other | — | -6.62M | 0 | -100% | — |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-08-28 | J | D | 6,618,033 | — | 0 | D | — | — | (F1) In-kind pro rata distribution by Valor IV Pharma Holdings, LLC, without consideration. |